Skip to product information
1 of 1

Elabscience

SKU:E-EL-H6018

Human MAU(Microalbuminuria) ELISA Kit

Human MAU(Microalbuminuria) ELISA Kit

Regular price $495.00 USD
Regular price Sale price $495.00 USD
Sale Sold out
Shipping calculated at checkout.
Size

The Human MAU (Microalbuminuria) ELISA Kit is a cutting-edge diagnostic tool designed to accurately measure the levels of microalbuminuria in human urine samples. Microalbuminuria is a condition characterized by the presence of small amounts of albumin in the urine, which can be an early indicator of kidney damage or dysfunction. This ELISA kit utilizes a highly sensitive and specific enzyme-linked immunosorbent assay (ELISA) technique to detect and quantify microalbuminuria, providing healthcare professionals with valuable insights into renal health.

This comprehensive kit includes all the necessary components for a successful microalbuminuria analysis. It contains microtiter plates pre-coated with specific antibodies that selectively bind to albumin molecules in the urine samples. The kit also includes a set of standards with known concentrations of microalbuminuria, allowing for the creation of a standard curve to accurately determine the concentration of microalbuminuria in the samples. Additionally, the kit provides all the reagents and buffers required for the assay, ensuring consistent and reliable results.

The Human MAU ELISA Kit offers numerous advantages for healthcare professionals and researchers. Its high sensitivity enables the detection of microalbuminuria at very low concentrations, ensuring early detection and intervention in patients at risk of kidney damage. The kit's specificity ensures minimal cross-reactivity with other proteins, guaranteeing accurate and reliable results. Furthermore, the kit's user-friendly protocol and clear instructions make it suitable for both experienced laboratory technicians and beginners. With its exceptional performance and ease of use, the Human MAU ELISA Kit is an indispensable tool for monitoring renal health and improving patient outcomes.

View full details